|
EP1536839B1
(en)
|
|
Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
|
|
US5468729A
(en)
|
|
Method for treatment of autoimmune hepatitis
|
|
US5491150A
(en)
|
|
Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
|
|
AU2002363248B2
(en)
|
|
Method of administering a Thymosin alpha 1 peptide
|
|
US6362162B1
(en)
|
|
CML Therapy
|
|
EP1023901A1
(en)
|
|
Ameliorant for hepatitis c remedial effect and application thereof
|
|
EP0731710B1
(en)
|
|
Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease
|
|
JP2784401B2
(ja)
|
|
慢性骨髄性白血病の治療方法
|
|
AU685413B2
(en)
|
|
Method and composition for treatment of patients having decompensated liver disease
|
|
HK1021685B
(zh)
|
|
用於治療肝功能失代償性肝臟疾病的含胸腺素α1的組合物
|
|
US5750501A
(en)
|
|
Method and composition for treatment of patients having decompensated liver disease
|
|
US5317012A
(en)
|
|
Human growth hormone induced improvement in depressed T4/T8 ratio
|
|
JP2000506839A
(ja)
|
|
天然ヒトα―インターフェロンを含む薬剤組成物
|
|
JP3869874B2
(ja)
|
|
急性肝不全治療剤
|
|
NZ258326A
(en)
|
|
The use, in the preparation of a medicament, of thymosin alpha 1 for treatment of patients having decompensated liver disease
|
|
AU777456B2
(en)
|
|
CML therapy
|
|
JPH0651639B2
(ja)
|
|
後天性免疫不全に関係した骨髄抑止の治療
|
|
EP0315300A2
(en)
|
|
Treatment of tuberculous and nontuberculous mycobacterial infection
|
|
JP2006232862A
(ja)
|
|
代償不全肝疾患の患者の治療のための組成物
|
|
JPH07188050A
(ja)
|
|
ミニマルｂ型肝炎感染症治療用医薬組成物
|
|
PT1535622E
(pt)
|
|
Terapia de melanoma
|
|
HK1075418A
(zh)
|
|
慢性骨髓性白血病治疗
|
|
MXPA94008106A
(en)
|
|
Use of alpha1 timosine and a corticoesteroide, and sucposposition for the treatment of hepatitisautoinm
|
|
HK1032348B
(zh)
|
|
慢性骨髓白血病(cml)治疗
|
|
WO2001080877A1
(en)
|
|
Preventives for reinfection after liver transplantation
|